![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 16, 13952-13958, April 18, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Molecular Genetics and Microbiology, State
University of New York at Stony Brook,
Stony Brook, New York, 11794-5222
Src homology containing phosphotyrosine
phosphatase 2 (SHP2) is a positive effector of growth factor, cytokine,
and integrin signaling. However, neither its physiological substrate
nor its mechanism of action in tyrosine kinase signaling has been
demonstrated. We reasoned that the identification of physiological
substrates of SHP2 would be a stepping stone in elucidating its
mechanism of action, and, thus, we constructed a potent trapping mutant of SHP2. Surprisingly, the frequently used Asp to Ala substitution did
not give rise to a trapping mutant. However, we were able to develop an
efficient trapping mutant of SHP2 by introducing Asp to Ala and Cys to
Ser double mutations. The double mutant (DM) protein identified the
epidermal growth factor receptor (EGFR), the Grb2 binder 1, and three
other, as yet unidentified, phosphotyrosyl proteins as candidate
physiological substrates. Given that substrate trapping occurred in
intact cells and that the interaction was very specific, it is highly
likely that EGFR and Gab1 represent physiological SHP2 substrates.
Therefore, the DM protein would serve as an important tool in future
SHP2 studies, including identification of p190, p150, and p90.
To whom correspondence should be addressed. Tel.: 631-632-8792;
Fax: 631-632-8891; E-mail: mhayman@ms.cc.sunysb.edu.
This article has been cited by other articles:
![]() |
J. Wu, A. Katrekar, L. A. Honigberg, A. M. Smith, M. T. Conn, J. Tang, D. Jeffery, K. Mortara, J. Sampang, S. R. Williams, et al. Identification of Substrates of Human Protein-tyrosine Phosphatase PTPN22 J. Biol. Chem., April 21, 2006; 281(16): 11002 - 11010. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Tsutsumi, A. Takahashi, T. Azuma, H. Higashi, and M. Hatakeyama Focal Adhesion Kinase Is a Substrate and Downstream Effector of SHP-2 Complexed with Helicobacter pylori CagA Mol. Cell. Biol., January 1, 2006; 26(1): 261 - 276. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-M. Sturla, G. Amorino, M. S. Alexander, R. B. Mikkelsen, K. Valerie, and R. K. Schmidt-Ullrichr Requirement of Tyr-992 and Tyr-1173 in Phosphorylation of the Epidermal Growth Factor Receptor by Ionizing Radiation and Modulation by SHP2 J. Biol. Chem., April 15, 2005; 280(15): 14597 - 14604. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Montagner, A. Yart, M. Dance, B. Perret, J.-P. Salles, and P. Raynal A Novel Role for Gab1 and SHP2 in Epidermal Growth Factor-induced Ras Activation J. Biol. Chem., February 18, 2005; 280(7): 5350 - 5360. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhan and D. M. O'Rourke SHP-2-Dependent Mitogen-Activated Protein Kinase Activation Regulates EGFRvIII but not Wild-Type Epidermal Growth Factor Receptor Phosphorylation and Glioblastoma Cell Survival Cancer Res., November 15, 2004; 64(22): 8292 - 8298. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kolli, C. I. Zito, M. H. Mossink, E. A. C. Wiemer, and A. M. Bennett The Major Vault Protein Is a Novel Substrate for the Tyrosine Phosphatase SHP-2 and Scaffold Protein in Epidermal Growth Factor Signaling J. Biol. Chem., July 9, 2004; 279(28): 29374 - 29385. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Holgado-Madruga and A. J. Wong Role of the Grb2-Associated Binder 1/SHP-2 Interaction in Cell Growth and Transformation Cancer Res., March 15, 2004; 64(6): 2007 - 2015. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. M. Agazie and M. J. Hayman Molecular Mechanism for a Role of SHP2 in Epidermal Growth Factor Receptor Signaling Mol. Cell. Biol., November 1, 2003; 23(21): 7875 - 7886. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |